Method for determining diet program effectiveness

• US 5,639,471 A
• Filed: 06/06/1995
• Issued: 06/17/1997
• Est. Priority Date: 06/06/1995
• Status: Expired due to Term

• Current Assignee: Culinary Health Innovations, LLC
• Original Assignee: Campbell Soup Company
• Inventors: Stern, Judith S., Hatton, Dan, McCarron, David, Kris-Etherton, Penny, Resnick, Larry, Pi-Sunyer, Xavier, Macnair, R. David C., Chait, Allen, Metz, Jill, Haynes, R. Brian, Oparil, Suzanne, Ziegler, Paula J., Khoo, Chor San Heng
• Primary Examiner(s): Page, Thurman K.
• Assistant Examiner(s): Shelborne, Kathryne E.
• Application Number:
  US08/469,516
• Time in Patent Office: 742 Days
• Field of Search: 424/439, 424/400, 424/440
• US Class Current: 424/439
• CPC Class Codes: A23L 33/30 Dietetic or nutritional methods, e.g. for losing weight A23L33/10 takes precedence
• CPC Class Codes: A61B 5/00 Measuring for diagnostic purposes radiation diagnosis A61B6/00; diagnosis by ultrasonic, sonic or infrasonic waves A61B8/00; Identification of persons
• CPC Class Codes: A61B 5/14507 specially adapted for measuring characteristics of body fluids other than blood devices for taking samples of body liquids A61B10/0045
• CPC Class Codes: A61B 5/20 for measuring urological functions restricted to the evaluation of the urinary system A61B5/4375 takes precedence

Abstract

The invention is a method for determining the effectiveness of a diet program for administration to a patient having at least one diet-responsive condition. The method includes the steps of selecting a plurality of patients, each having at least one diet-responsive condition; identifying at least one quantifiable indicator of each of the diet-responsive conditions and measuring the at least one indicator for each of the patient during a four week baseline period; and monitoring each of the patients during the baseline period to determine a baseline quality of life. The plurality of patient are divided randomly between a first group and a second group. The diet program is administered to each of the patients in the first group during a ten week intervention period and each of the patient in the second group is maintained on a control diet with known beneficial effects on the at least one diet-responsive condition during the intervention period. The at least one indicator of each of the conditions is monitored for each of the patient after the intervention period.

Claims

1. A method for determining the effectiveness of a diet program for administration to a patient having at least one diet-responsive condition comprising the steps of:

selecting a plurality of patients, each having at least one diet-responsive condition;

identifying at least one quantifiable indicator of each of said diet-responsive conditions and measuring said at least one indicator for each of said patients during a baseline period;

monitoring each of said patients during said baseline period to determine a baseline quality of life;

dividing said plurality of patients randomly between a first group and a second group;

administering said diet program to each of said patients in said first group during an intervention period;

maintaining each of said patients in said second group on a control diet with known beneficial effects on said at least one diet-responsive condition during said intervention period; and

monitoring said at least one indicator of each of said conditions for each of said patients after said intervention period.

2. The method of claim 1, wherein said diet program comprises a plurality of prepackaged individual meals, wherein each of said individual meals contains a predetermined level of nutritional enhancement, whereby consumption of a daily diet comprising a plurality of said individual meals supplies said patient with a desired total daily calorie content, improved quality of life, and sufficient nutritional enhancement to facilitate management of said diet-responsive condition.

3. The method of claim 1, further comprising the step of testing each of said patients for urinary electrolyte excretion at a beginning and an end of said baseline period and after said intervention period.

4. The method of claim 1, further comprising the step of monitoring each of said patients to determine quality of life after said intervention period.

5. The method of claim 1, further comprising the steps of:

determining initial serum vitamin, iron, and trace mineral levels for each of said patients at a beginning and an end of said baseline period and after said intervention period; and

determining dietary safety by assessing changes in serum vitamin, iron, and trace mineral levels at a beginning and an end of said baseline period after said intervention period.

6. The method of claim 1, wherein said baseline period is four weeks.

7. The method of claim 1, wherein said intervention period is ten weeks.